Ibuprofen 400MG/600MG/800MG Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D223R0008
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support, a federal office, issued a solicitation under procurement identifier SPE2D223R0008 for the supply of Ibuprofen Tablets in 400MG, 600MG, and 800MG dosages. This procurement falls under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on drugs and biologicals.
The primary objective of this solicitation is to secure a reliable source of Ibuprofen tablets to support the medical needs of military personnel and associated federal entities. The scope encompasses the manufacturing and delivery of pharmaceutical-grade Ibuprofen in specified strengths, ensuring compliance with all applicable regulatory standards for safety, efficacy, and quality. Contractors are expected to provide products that meet rigorous specifications suitable for federal use, with the intended outcome of maintaining a consistent and dependable supply chain for these essential medications.
Key requirements include the ability to manufacture and supply Ibuprofen tablets in the 400MG, 600MG, and 800MG strengths. Prospective contractors must demonstrate capacity for large-scale pharmaceutical production, adherence to current Good Manufacturing Practices (cGMP), and capability to meet federal procurement standards. Deliverables are expected to include timely delivery of the specified dosages, with all necessary documentation and certifications as required by federal regulations.
The contracting entity for this opportunity is DLA Troop Support, located in Philadelphia, PA. Interested parties may direct inquiries to the primary contact, Christopher Newman ([email protected], 215-737-2905), or the secondary contact, Kristen Baraniewicz ([email protected], 215-737-4484). The solicitation was posted on May 18, 2023, with a response deadline of June 2, 2023. As of now, the notice status is inactive.
This procurement is a federal solicitation, and while specific set-aside requirements or special considerations are not detailed in the notice, contractors should be prepared to comply with all federal acquisition regulations and standards relevant to pharmaceutical supply contracts. The opportunity was originally posted on SAM.gov, and further details, including attachments, can be accessed via the provided notice URL.
Contractors evaluating this opportunity should consider their ability to consistently deliver high-quality pharmaceutical products, maintain compliance with federal standards, and support the logistical needs of DLA Troop Support over the contract lifecycle. The requirements for manufacturing, regulatory compliance, and reliable delivery will remain constant throughout the duration of the contract.